On the public citation graph

Can you teach old drugs new tricks?

0 signed · 731 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/j.ddstr.2011.06.005openalex-snapshot
Literature analysis for systematic drug repurposing: a case study from Biovista
inferredcites →https://doi.org/10.1038/ncomms2320openalex-snapshot
A safe lithium mimetic for bipolar disorder
inferredcites →https://doi.org/10.1038/npp.2015.343openalex-snapshot
Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans
inferredcites →https://doi.org/10.1038/nrd3681openalex-snapshot
Diagnosing the decline in pharmaceutical R&D efficiency

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/2211-5463.13796openalex-snapshot
Signature reversion of three disease‐associated gene signatures prioritizes cancer drug repurposing candidates
inferred← citeshttps://doi.org/10.1002/9783527841165.ch15openalex-snapshot
Current Updates in Breast Cancer Drugs
inferred← citeshttps://doi.org/10.1002/adhm.202501355openalex-snapshot
Controlling the Organization and Differentiation of Human Neural Stem Cells on Hilbert Microcapillary Scaffolds Fabricated via Two‐Photon Lithography
inferred← citeshttps://doi.org/10.1002/advs.202304203openalex-snapshot
Targeting GRP75 with a Chlorpromazine Derivative Inhibits Endometrial Cancer Progression Through GRP75–IP3R‐Ca 2+ ‐AMPK Axis
inferred← citeshttps://doi.org/10.1002/ajmg.c.32153openalex-snapshot
CURE ID : A Platform to Collect Real‐World Treatment Data for Drug Repurposing in Rare Genetic Disorders
inferred← citeshttps://doi.org/10.1002/ardp.201600289openalex-snapshot
Drotaverine – a Concealed Cytostatic!
inferred← citeshttps://doi.org/10.1002/bab.70193openalex-snapshot
Repurposing FDA‐Approved Antiviral Drugs Ganciclovir and Acyclovir Against Respiratory Syncytial Virus Nucleoprotein: Molecular Docking, ADMET, PASS, and Molecular Dynamics Simulations
inferred← citeshttps://doi.org/10.1002/bcp.70875openalex-snapshot
Defining a comprehensive set of value assessment criteria for funders of drug repurposing initiatives
inferred← citeshttps://doi.org/10.1002/cmdc.201600477openalex-snapshot
A Quinacrine Analogue Selective Against Gastric Cancer Cells: Insight from Biochemical and Biophysical Studies
inferred← citeshttps://doi.org/10.1002/cmdc.202000677openalex-snapshot
Therapeutic Strategies To Counteract Antibiotic Resistance in MRSA Biofilm‐Associated Infections
inferred← citeshttps://doi.org/10.1002/cmdc.202500747openalex-snapshot
Enhancing Drug Repurposing with Consensus Docking: Discovery of Novel Discoidin Domain Receptor 1 Inhibitors
inferred← citeshttps://doi.org/10.1002/ddr.21673openalex-snapshot
Prospects of multitarget drug designing strategies by linking molecular docking and molecular dynamics to explore the protein–ligand recognition process
inferred← citeshttps://doi.org/10.1002/jbmr.4904openalex-snapshot
Genetic Correlation, Shared Loci, and Causal Association Between Sex Hormone-Binding Globulin and Bone Mineral Density: Insights From a Large-Scale Genomewide Cross-Trait Analysis
inferred← citeshttps://doi.org/10.1002/jcb.26731openalex-snapshot
Ebselen inhibits the activity of acetylcholinesterase globular isoform G4 in vitro and attenuates scopolamine‐induced amnesia in mice
inferred← citeshttps://doi.org/10.1002/mbo3.70269openalex-snapshot
Ionomycin Exhibits Potent and Selective Bactericidal Activity Against Clostridioides difficile Through Calcium‐Dependent Membrane Disruption
inferred← citeshttps://doi.org/10.1002/med.21645openalex-snapshot
The aryl hydrocarbon receptor (AhR) as a breast cancer drug target
inferred← citeshttps://doi.org/10.1002/med.22033openalex-snapshot
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies
inferred← citeshttps://doi.org/10.1002/minf.202300206openalex-snapshot
Similarity searching for anticandidal agents employing a repurposing approach
inferred← citeshttps://doi.org/10.1002/minf.202300336openalex-snapshot
Exploring drug repositioning possibilities of kinase inhibitors via molecular simulation**
inferred← citeshttps://doi.org/10.1002/pds.5015openalex-snapshot
Identifying drugs with disease‐modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology
inferred← citeshttps://doi.org/10.1002/pds.5176openalex-snapshot
Using artificial intelligence to identify anti‐hypertensives as possible disease modifying agents in Parkinson's disease
inferred← citeshttps://doi.org/10.1002/pmic.202400109openalex-snapshot
Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches
inferred← citeshttps://doi.org/10.1002/slct.202500093openalex-snapshot
In Silico Evaluation of Approved Drug Library to Discover Tyrosine Threonine Kinase Inhibitors for Colon Cancer
inferred← citeshttps://doi.org/10.1002/slct.202506782openalex-snapshot
Drug Repurposing in Cancer Therapy: A Review of Therapeutic Potential Across Diverse Drug Classes
inferred← citeshttps://doi.org/10.1002/tcr.202100014openalex-snapshot
Fresh Molecular Concepts to Extend the Lifetimes of Old Antimicrobial Drugs
inferred← citeshttps://doi.org/10.1002/wcms.70004openalex-snapshot
Strategies for Redesigning Withdrawn Drugs to Enhance Therapeutic Efficacy and Safety: A Review
inferred← citeshttps://doi.org/10.1007/5584_2022_744openalex-snapshot
Application of Drug Repurposing-Based Precision Medicine Platform for Leukaemia Patient Treatment
inferred← citeshttps://doi.org/10.1007/5584_2025_863openalex-snapshot
Combination Therapies in Drug Repurposing: Personalized Approaches to Combatting Leukaemia and Multiple Myeloma
inferred← citeshttps://doi.org/10.1007/978-1-0716-2513-2_17openalex-snapshot
Drug Target Prediction Using Context-Specific Metabolic Models Reconstructed from rFASTCORMICS
inferred← citeshttps://doi.org/10.1007/978-1-4939-9089-4_6openalex-snapshot
Leveraging Big Data to Transform Drug Discovery
inferred← citeshttps://doi.org/10.1007/978-3-030-32857-3_4openalex-snapshot
Mining Complex Biomedical Literature for Actionable Knowledge on Rare Diseases
inferred← citeshttps://doi.org/10.1007/978-3-030-42783-2_7openalex-snapshot
Computational Modeling of Nonlinear Phenomena Using Machine Learning
inferred← citeshttps://doi.org/10.1007/978-3-031-13829-4_47openalex-snapshot
An Optimization Method for Drug-Target Interaction Prediction Based on RandSAS Strategy
inferred← citeshttps://doi.org/10.1007/978-3-031-60843-8_15openalex-snapshot
Operation and Other Considerations
inferred← citeshttps://doi.org/10.1007/978-3-031-94101-6_11openalex-snapshot
Drug Discovery and Development for Neurodegenerative Diseases Using Induced Pluripotent Stem Cells
inferred← citeshttps://doi.org/10.1007/978-3-032-01636-2_11openalex-snapshot
Rare Diseases and Orphan Drugs: Innovation Through Repurposing Strategies
inferred← citeshttps://doi.org/10.1007/978-3-319-67045-4_9openalex-snapshot
Natural Products as Antiparasitic Agents
inferred← citeshttps://doi.org/10.1007/978-3-662-57611-3_2openalex-snapshot
Big Data in Gesundheitswesen und Medizin
inferred← citeshttps://doi.org/10.1007/978-981-13-3672-0_1openalex-snapshot
Clinical Potential of Induced Pluripotent Stem Cells
inferred← citeshttps://doi.org/10.1007/978-981-16-9221-5_15openalex-snapshot
Computational Intelligence-Based Cheminformatics Model as Cancer Therapeutics
inferred← citeshttps://doi.org/10.1007/978-981-16-9232-1_3openalex-snapshot
Drug Repurposing in Biomedical Research: Benefits and Challenges
inferred← citeshttps://doi.org/10.1007/978-981-16-9232-1_5openalex-snapshot
Genomic Approaches for Drug Repositioning
inferred← citeshttps://doi.org/10.1007/978-981-19-5399-6_1openalex-snapshot
Drug Repurposing: An Advance Way to Traditional Drug Discovery
inferred← citeshttps://doi.org/10.1007/978-981-19-5399-6_22openalex-snapshot
Drug Repurposing in COVID-19 and Cancer: How Far Have We Come?
inferred← citeshttps://doi.org/10.1007/978-981-19-5399-6_25openalex-snapshot
Repurposing of Therapeutic Approaches for the Treatment of Vitiligo
inferred← citeshttps://doi.org/10.1007/978-981-95-4522-3_1openalex-snapshot
Role of Industry–Academia Collaboration in the Translational Success of Drug Repurposing
inferred← citeshttps://doi.org/10.1007/978-981-95-4522-3_2openalex-snapshot
Drug Repurposing: Exploring Newer Therapeutic Potentials
inferred← citeshttps://doi.org/10.1007/s00011-026-02293-8openalex-snapshot
Repurposing niclosamide to mitigate inflammaging: a review of multi-target mechanisms in cellular senescence and age-related decline
inferred← citeshttps://doi.org/10.1007/s00018-016-2419-3openalex-snapshot
Old drugs with new skills: fenoprofen as an allosteric enhancer at melanocortin receptor 3
inferred← citeshttps://doi.org/10.1007/s00044-024-03226-yopenalex-snapshot
Synthesis and antiviral property of polysulfate-grafted maleimide-based enediynes
inferred← citeshttps://doi.org/10.1007/s00213-018-4855-2openalex-snapshot
From gene networks to drugs: systems pharmacology approaches for AUD
inferred← citeshttps://doi.org/10.1007/s00284-025-04310-1openalex-snapshot
Antibacterial Synergism of Fluoxetine and Paroxetine with Ceftriaxone, Plasmid DNA Cleavage and Repositioning
inferred← citeshttps://doi.org/10.1007/s00436-020-06901-2openalex-snapshot
Evaluation of the efficacy of albendazole sulfoxide (ABZ-SO)–loaded chitosan-PLGA nanoparticles in the treatment of cystic echinococcosis in laboratory mice
inferred← citeshttps://doi.org/10.1007/s00894-023-05492-wopenalex-snapshot
A compact review of progress and prospects of deep learning in drug discovery
inferred← citeshttps://doi.org/10.1007/s10096-017-3114-5openalex-snapshot
Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections
inferred← citeshttps://doi.org/10.1007/s11033-023-08568-1openalex-snapshot
The evidence for repurposing anti-epileptic drugs to target cancer
inferred← citeshttps://doi.org/10.1007/s11095-026-04065-9openalex-snapshot
REAL208, a Liposome-based Formulation of Phosphodiesterase Inhibitor, Protects Acute Kidney Deficiency in Mice
inferred← citeshttps://doi.org/10.1007/s11192-026-05596-zopenalex-snapshot
Information characteristics of patents and academic papers for drug repurposing
inferred← citeshttps://doi.org/10.1007/s11224-022-02020-zopenalex-snapshot
Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
inferred← citeshttps://doi.org/10.1007/s11298-018-6544-1openalex-snapshot
Heilen mittels Wirkstoff-Recycling
inferred← citeshttps://doi.org/10.1007/s11427-024-2790-7openalex-snapshot
Peficitinib suppresses diffuse-type tenosynovial giant cell tumor by targeting TYK2 and JAK/STAT signaling
inferred← citeshttps://doi.org/10.1007/s11912-025-01721-yopenalex-snapshot
The Expendables: Overlooked Medications with Anti-Cancer Properties
inferred← citeshttps://doi.org/10.1007/s12011-026-05296-yopenalex-snapshot
Protective Effects of Metformin and Memantine Against Arsenic-Induced Neurotoxicity: Insights from In-Silico and In-Vivo Studies
inferred← citeshttps://doi.org/10.1007/s12035-018-1374-4openalex-snapshot
PDE3 Inhibitors Repurposed as Treatments for Age-Related Cognitive Impairment
inferred← citeshttps://doi.org/10.1007/s12038-020-00067-wopenalex-snapshot
Drug targets for COVID-19 therapeutics: Ongoing global efforts
inferred← citeshttps://doi.org/10.1007/s12247-022-09688-0openalex-snapshot
Design, Development, In Silico, and In Vitro Characterization of Camptothecin-Loaded Mixed Micelles: In Vitro Testing of Verapamil and Ranolazine for Repurposing as Coadjuvant Therapy in Cancer
inferred← citeshttps://doi.org/10.1007/s12274-022-4457-5openalex-snapshot
Metformin capped Cu2(OH)3Cl nanosheets for chemodynamic wound disinfection
inferred← citeshttps://doi.org/10.1007/s12519-024-00834-xopenalex-snapshot
Next-generation pediatric care: nanotechnology-based and AI-driven solutions for cardiovascular, respiratory, and gastrointestinal disorders
inferred← citeshttps://doi.org/10.1007/s12539-025-00747-xopenalex-snapshot
Subgraph Neural Networks Enhanced by Global Similarity for Drug Repositioning
inferred← citeshttps://doi.org/10.1007/s12975-022-01000-zopenalex-snapshot
Recycled Translation: Repurposing Drugs for Stroke
inferred← citeshttps://doi.org/10.1007/s40263-025-01223-2openalex-snapshot
Sigma-1 Receptor Ligands for CNS Cancer Treatment
inferred← citeshttps://doi.org/10.1007/s40319-021-01088-0openalex-snapshot
Has the EU Incentive for Drug Repositioning Been Effective? An Empirical Analysis of the “+1” Regulatory Exclusivity
inferred← citeshttps://doi.org/10.1007/s40319-025-01662-wopenalex-snapshot
Between Patents and Patients: Why Intellectual Property Alone Cannot Sustain Drug Repurposing
inferred← citeshttps://doi.org/10.1007/s43253-025-00156-2openalex-snapshot
What financialisation is doing to access to healthcare: price and value of medicines in financial capitalism
inferred← citeshttps://doi.org/10.1007/s43630-024-00535-4openalex-snapshot
Oral intake of bucillamine, carvedilol, metformin, or phenformin does not protect against UVR-induced squamous cell carcinomas in hairless mice
inferred← citeshttps://doi.org/10.1016/b978-0-12-816125-8.00003-1openalex-snapshot
In Silico Drug Design Methods for Drug Repurposing
inferred← citeshttps://doi.org/10.1016/b978-0-12-816573-7.00004-3openalex-snapshot
Understanding Human Genetic Disease With the Fly
inferred← citeshttps://doi.org/10.1016/b978-0-12-819668-7.00012-9openalex-snapshot
Drugs repurposed to potentiate immunotherapy for cancer treatment
inferred← citeshttps://doi.org/10.1016/b978-0-12-819668-7.00015-4openalex-snapshot
Clinical trials on combination of repurposed drugs and anticancer therapies
inferred← citeshttps://doi.org/10.1016/b978-0-12-821100-7.00007-8openalex-snapshot
Drug repurposing and nanoparticles: New strategies against leishmaniasis
inferred← citeshttps://doi.org/10.1016/b978-0-12-823974-2.00028-0openalex-snapshot
Nonheme mono- and dioxygenases
inferred← citeshttps://doi.org/10.1016/b978-0-323-89777-8.00001-4openalex-snapshot
Use of artificial intelligence in pharmacovigilance for social media network
inferred← citeshttps://doi.org/10.1016/b978-0-323-91817-6.00017-6openalex-snapshot
New drug discovery and development
inferred← citeshttps://doi.org/10.1016/b978-0-323-99873-4.00009-8openalex-snapshot
Repurposing drugs in glioblastoma
inferred← citeshttps://doi.org/10.1016/b978-0-443-15232-0.00021-7openalex-snapshot
New targets for old drugs
inferred← citeshttps://doi.org/10.1016/b978-0-443-15280-1.00013-3openalex-snapshot
Drug discovery and repositioning for glioblastoma multiforme and low-grade astrocytic tumors
inferred← citeshttps://doi.org/10.1016/b978-0-443-23763-8.00005-1openalex-snapshot
Medical potentials of natural neuroprotectants derived from herbal extracts and their phytochemicals
inferred← citeshttps://doi.org/10.1016/b978-0-443-29808-0.00011-xopenalex-snapshot
Introduction to GPCRs
inferred← citeshttps://doi.org/10.1016/b978-0-443-31656-2.00005-0openalex-snapshot
Lung cancer: Current status of preclinical research
inferred← citeshttps://doi.org/10.1016/b978-0-443-36518-8.00014-xopenalex-snapshot
Drug repurposing: Innovative antimicrobial strategies for discovering new antibiotics
inferred← citeshttps://doi.org/10.1016/bs.apcsb.2022.05.006openalex-snapshot
From single-omics to interactomics: How can ligand-induced perturbations modulate single-cell phenotypes?
inferred← citeshttps://doi.org/10.1016/bs.irn.2024.02.002openalex-snapshot
Repurposing drugs for treatment of alcohol use disorder
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2024.02.006openalex-snapshot
Drug repurposing for metabolic disorders: Scientific, technological and economic issues
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2024.03.026openalex-snapshot
An overview to drug repurposing
inferred← citeshttps://doi.org/10.1016/j.addr.2023.115007openalex-snapshot
Confronting antifungal resistance, tolerance, and persistence: Advances in drug target discovery and delivery systems
inferred← citeshttps://doi.org/10.1016/j.advms.2023.06.001openalex-snapshot
Sertraline as a potential cancer therapeutic approach: Biological relevance of TCTP in breast cancer cell lines and tumors
inferred← citeshttps://doi.org/10.1016/j.artmed.2025.103218openalex-snapshot
AI-based mining of biomedical literature: Applications for drug repurposing for the treatment of dementia
inferred← citeshttps://doi.org/10.1016/j.asoc.2021.107633openalex-snapshot
Predictive intelligence powered attentional stacking matrix factorization algorithm for the computational drug repositioning
inferred← citeshttps://doi.org/10.1016/j.bbagen.2018.07.022openalex-snapshot
Structural basis for the hepatoprotective effects of antihypertensive 1,4-dihydropyridine drugs
inferred← citeshttps://doi.org/10.1016/j.bcp.2020.114403openalex-snapshot
Chlorpromazine, an antipsychotic agent, induces G2/M phase arrest and apoptosis via regulation of the PI3K/AKT/mTOR-mediated autophagy pathways in human oral cancer
inferred← citeshttps://doi.org/10.1016/j.bcp.2021.114452openalex-snapshot
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine
inferred← citeshttps://doi.org/10.1016/j.bcp.2025.117066openalex-snapshot
Novel aryl hydrocarbon receptor agonists as potential anti-inflammatory therapeutics: Identification and validation through drug repurposing
inferred← citeshttps://doi.org/10.1016/j.bioorg.2021.104971openalex-snapshot
Nitrofurazone repurposing towards design and synthesis of novel apoptotic-dependent anticancer and antimicrobial agents: Biological evaluation, kinetic studies and molecular modeling
inferred← citeshttps://doi.org/10.1016/j.biopha.2017.05.045openalex-snapshot
Recent trends in ZikV research: A step away from cure
inferred← citeshttps://doi.org/10.1016/j.biopha.2018.12.119openalex-snapshot
Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: An underestimated truth
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.112375openalex-snapshot
Drugs repurposed: An advanced step towards the treatment of breast cancer and associated challenges
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.113850openalex-snapshot
Assessing the potential of repurposing ion channel inhibitors to treat emerging viral diseases and the role of this host factor in virus replication
inferred← citeshttps://doi.org/10.1016/j.biopha.2025.118621openalex-snapshot
Modelling-filtered drug repurposing and first-in-protein SPR validation of histone deacetylase 4 inhibitors for Ataxia-telangiectasia
inferred← citeshttps://doi.org/10.1016/j.biopha.2025.118885openalex-snapshot
Drug repurposing in gynaecological cancers: Proven drugs for new challenges
inferred← citeshttps://doi.org/10.1016/j.biopha.2026.119575openalex-snapshot
Standardized workflow enables reproducibility of drug synergism detection: Results from a multi-center in vitro ring test on complex drug combinations in pancreatic cancer models
inferred← citeshttps://doi.org/10.1016/j.bmcl.2021.128383openalex-snapshot
Searching for an ideal SERM: Mining tamoxifen structure–activity relationships
inferred← citeshttps://doi.org/10.1016/j.bpc.2022.106891openalex-snapshot
Computational pharmacology: New avenues for COVID-19 therapeutics search and better preparedness for future pandemic crises
inferred← citeshttps://doi.org/10.1016/j.canlet.2018.06.034openalex-snapshot
Targeting cancer stem cells with dietary phytochemical - Repositioned drug combinations
inferred← citeshttps://doi.org/10.1016/j.cej.2025.169456openalex-snapshot
Full-active-ingredient nanoparticles loaded with salmon calcitonin potentiate antioxidation and lubrication for osteoarthritis therapy
inferred← citeshttps://doi.org/10.1016/j.cellsig.2019.109425openalex-snapshot
Differentiation of human neuroblastoma cell line IMR-32 by sildenafil and its newly discovered analogue IS00384
inferred← citeshttps://doi.org/10.1016/j.chemphyslip.2021.105072openalex-snapshot
The interplay between lipid and Aβ amyloid homeostasis in Alzheimer’s Disease: risk factors and therapeutic opportunities
inferred← citeshttps://doi.org/10.1016/j.coisb.2017.04.010openalex-snapshot
Drug repositioning beyond the low-hanging fruits
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2022.105575openalex-snapshot
Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2023.106671openalex-snapshot
Computational drug repurposing by exploiting large-scale gene expression data: Strategy, methods and applications
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2023.107231openalex-snapshot
Leveraging decagonal in-silico strategies for uncovering IL-6 inhibitors with precision
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2024.108612openalex-snapshot
CKG-IMC: An inductive matrix completion method enhanced by CKG and GNN for Alzheimer’s disease compound-protein interactions prediction
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2024.109415openalex-snapshot
Transcriptome analysis displays new molecular insights into the mechanisms of action of Mebendazole in gastric cancer cells
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2025.109665openalex-snapshot
Sirolimus as a repurposed drug for tendinopathy: A systems biology approach combining computational and experimental methods
inferred← citeshttps://doi.org/10.1016/j.conb.2025.103132openalex-snapshot
Towards the establishment of treatments for neurodegenerative diseases using human iPSCs
inferred← citeshttps://doi.org/10.1016/j.csbj.2020.04.004openalex-snapshot
Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
inferred← citeshttps://doi.org/10.1016/j.cyto.2023.156143openalex-snapshot
Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2021.03.003openalex-snapshot
Biological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease
inferred← citeshttps://doi.org/10.1016/j.drudis.2016.06.026openalex-snapshot
Open for collaboration: an academic platform for drug discovery and development at SciLifeLab
inferred← citeshttps://doi.org/10.1016/j.drudis.2017.09.007openalex-snapshot
Uncovering novel repositioning opportunities using the Open Targets platform
inferred← citeshttps://doi.org/10.1016/j.drudis.2018.06.012openalex-snapshot
Renovation as innovation: is repurposing the future of drug discovery research?
inferred← citeshttps://doi.org/10.1016/j.drudis.2018.07.010openalex-snapshot
AI-generated in silico data in patent applications
inferred← citeshttps://doi.org/10.1016/j.drudis.2019.09.019openalex-snapshot
The NCATS Pharmaceutical Collection: a 10-year update
inferred← citeshttps://doi.org/10.1016/j.drudis.2020.07.004openalex-snapshot
Recent advances in multitarget-directed ligands targeting G-protein-coupled receptors
inferred← citeshttps://doi.org/10.1016/j.drudis.2021.10.014openalex-snapshot
Knowledge-based approaches to drug discovery for rare diseases
inferred← citeshttps://doi.org/10.1016/j.drudis.2021.11.013openalex-snapshot
Repurposing drugs in autophagy for the treatment of cancer: From bench to bedside
inferred← citeshttps://doi.org/10.1016/j.drudis.2022.02.007openalex-snapshot
Teaching an old dog new tricks: Drug discovery by repositioning natural products and their derivatives
inferred← citeshttps://doi.org/10.1016/j.drudis.2022.03.021openalex-snapshot
Targeting Clostridioides difficile: New uses for old drugs
inferred← citeshttps://doi.org/10.1016/j.drudis.2024.104008openalex-snapshot
How health technology assessment can help to address challenges in drug repurposing: a conceptual framework
inferred← citeshttps://doi.org/10.1016/j.drudis.2024.104138openalex-snapshot
Preclinical alternative drug discovery programs for monogenic rare diseases. Should small molecules or gene therapy be used? The case of hereditary spastic paraplegias
inferred← citeshttps://doi.org/10.1016/j.drudis.2024.104286openalex-snapshot
Revising EU pharmaceutical legislation: will it foster drug repurposing?
inferred← citeshttps://doi.org/10.1016/j.drudis.2026.104807openalex-snapshot
Bridging the translational gap in drug repurposing for rare diseases: clinical success versus regulatory conversion
inferred← citeshttps://doi.org/10.1016/j.drudis.2026.104813openalex-snapshot
Patient-based evidence in mechanism-based drug repurposing: Challenges and recommendations
inferred← citeshttps://doi.org/10.1016/j.ebiom.2017.03.042openalex-snapshot
New Models for Therapeutic Innovation from Japan
inferred← citeshttps://doi.org/10.1016/j.ebiom.2019.11.046openalex-snapshot
Prioritization of novel ADPKD drug candidates from disease-stage specific gene expression profiles
inferred← citeshttps://doi.org/10.1016/j.ejmech.2016.09.051openalex-snapshot
Repurposing N,N'-bis-(arylamidino)-1,4-piperazinedicarboxamidines: An unexpected class of potent inhibitors of cholinesterases
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112471openalex-snapshot
Drug repurposing: Discovery of troxipide analogs as potent antitumor agents
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112676openalex-snapshot
Identification of the subtype-selective Sirt5 inhibitor balsalazide through systematic SAR analysis and rationalization via theoretical investigations
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112739openalex-snapshot
Azithromycin: The First Broad-spectrum Therapeutic
inferred← citeshttps://doi.org/10.1016/j.ejmech.2022.114239openalex-snapshot
Drug repositioning: Progress and challenges in drug discovery for various diseases
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.117164openalex-snapshot
Advanced AI and ML frameworks for transforming drug discovery and optimization: With innovative insights in polypharmacology, drug repurposing, combination therapy and nanomedicine
inferred← citeshttps://doi.org/10.1016/j.ejmech.2026.118987openalex-snapshot
Antiparasitic agents in oncology: Innovative mechanisms, emerging evidence and clinical potential in cancer treatment
inferred← citeshttps://doi.org/10.1016/j.ejpb.2019.05.004openalex-snapshot
Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities
inferred← citeshttps://doi.org/10.1016/j.ejphar.2018.04.023openalex-snapshot
Old wines in new bottles: Repurposing opportunities for Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.ejphar.2021.174569openalex-snapshot
Repurposing old molecules for new indications: Defining pillars of success from lessons in the past
inferred← citeshttps://doi.org/10.1016/j.ejphar.2022.174800openalex-snapshot
Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation
inferred← citeshttps://doi.org/10.1016/j.ejphar.2024.177141openalex-snapshot
Novel applications of metformin in the treatment of septic myocardial injury based on metabolomics and network pharmacology
inferred← citeshttps://doi.org/10.1016/j.eplepsyres.2019.02.010openalex-snapshot
Network pharmacology for antiepileptogenesis: Tolerability and neuroprotective effects of novel multitargeted combination treatments in nonepileptic vs. post-status epilepticus mice
inferred← citeshttps://doi.org/10.1016/j.esmoop.2022.100540openalex-snapshot
Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels
inferred← citeshttps://doi.org/10.1016/j.eswa.2024.124152openalex-snapshot
Drug repositioning based on tripartite cross-network embedding and graph convolutional network
inferred← citeshttps://doi.org/10.1016/j.future.2021.06.018openalex-snapshot
A computational drug repositioning model based on hybrid similarity side information powered graph neural network
inferred← citeshttps://doi.org/10.1016/j.heliyon.2021.e05948openalex-snapshot
Drug combination and repurposing for cancer therapy: the example of breast cancer
inferred← citeshttps://doi.org/10.1016/j.heliyon.2022.e10108openalex-snapshot
A new use for old drugs: identifying compounds with an anti-obesity effect using a high through-put semi-automated Caenorhabditis elegans screening platform
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e22382openalex-snapshot
A precise prognostic signature in CTNNB1-mutant hepatocellular carcinoma: Prognosis prediction and precision treatment exploration
inferred← citeshttps://doi.org/10.1016/j.ibmed.2023.100101openalex-snapshot
Machine learning for metabolomics research in drug discovery
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2023.127208openalex-snapshot
Atosiban and Rutin exhibit anti-mycobacterial activity - An integrated computational and biophysical insight toward drug repurposing strategy against Mycobacterium tuberculosis targeting its essential enzyme HemD
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.130614openalex-snapshot
Identification and characterization of repurposed small molecule inhibitors of Mycobacterium tuberculosis caseinolytic protease B (ClpB) as anti-mycobacterials
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.137003openalex-snapshot
Drug repurposing: An antidiabetic drug Ipragliflozin as Mycobacterium tuberculosis sirtuin-like protein inhibitor that synergizes with anti-tuberculosis drug isoniazid
inferred← citeshttps://doi.org/10.1016/j.ijpx.2024.100249openalex-snapshot
A drug repurposing approach of Atorvastatin calcium for its antiproliferative activity for effective treatment of breast cancer: In vitro and in vivo assessment
inferred← citeshttps://doi.org/10.1016/j.imu.2024.101612openalex-snapshot
Targeting KRAS G12C and G12S mutations in lung cancer: In silico drug repurposing and antiproliferative assessment on A549 cells
inferred← citeshttps://doi.org/10.1016/j.intimp.2018.09.013openalex-snapshot
Antimicrobial and immunomodulatory activity induced by loperamide in mycobacterial infections
inferred← citeshttps://doi.org/10.1016/j.intimp.2019.03.031openalex-snapshot
Inhibition of the TIRAP-c-Jun interaction as a therapeutic strategy for AP1-mediated inflammatory responses
inferred← citeshttps://doi.org/10.1016/j.jddst.2023.104187openalex-snapshot
The challenge of repurposing niclosamide: Considering pharmacokinetic parameters, routes of administration, and drug metabolism
inferred← citeshttps://doi.org/10.1016/j.jddst.2025.107633openalex-snapshot
Combined penciclovir and lysine therapy for improved management of Herpes virus lesions
inferred← citeshttps://doi.org/10.1016/j.jiph.2020.10.012openalex-snapshot
Combating COVID-19: The role of drug repurposing and medicinal plants
inferred← citeshttps://doi.org/10.1016/j.jmb.2025.169610openalex-snapshot
Repurposing Drug Explorer (ReDEx): A Tool for Integrating Disease Networks, Drug Similarity Algorithms and Functional Exploration Powered by Enalos Cloud Platform
inferred← citeshttps://doi.org/10.1016/j.jmgm.2021.107965openalex-snapshot
Graph convolutional network approach to investigate potential selective Limk1 inhibitors
inferred← citeshttps://doi.org/10.1016/j.jmii.2026.05.006openalex-snapshot
Beyond the stomach: Repurposing bismuth tripotassium dicitrate as a novel strategy against multidrug-resistant Mycobacterium abscessus
inferred← citeshttps://doi.org/10.1016/j.jpsychires.2018.11.021openalex-snapshot
A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2017.05.002openalex-snapshot
Design strategies of oxidosqualene cyclase inhibitors: Targeting the sterol biosynthetic pathway
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2018.09.001openalex-snapshot
Virtual screening and drug repositioning as strategies for the discovery of new antifungal inhibitors of oxidosqualene cyclase
inferred← citeshttps://doi.org/10.1016/j.jtauto.2020.100062openalex-snapshot
WITHDRAWN: Azithromycin: The First Broad-spectrum Therapeutic
inferred← citeshttps://doi.org/10.1016/j.kint.2023.02.010openalex-snapshot
Drug repurposing in autosomal dominant polycystic kidney disease
inferred← citeshttps://doi.org/10.1016/j.kint.2023.03.007openalex-snapshot
International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology
inferred← citeshttps://doi.org/10.1016/j.mcn.2020.103524openalex-snapshot
ALS, a cellular whodunit on motor neuron degeneration
inferred← citeshttps://doi.org/10.1016/j.mib.2020.05.012openalex-snapshot
How antibiotics work together: molecular mechanisms behind combination therapy
inferred← citeshttps://doi.org/10.1016/j.molmed.2016.09.006openalex-snapshot
Drug Repurposing: New Treatments for Zika Virus Infection?
inferred← citeshttps://doi.org/10.1016/j.molstruc.2020.129143openalex-snapshot
Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors
inferred← citeshttps://doi.org/10.1016/j.nbd.2020.105227openalex-snapshot
Systematic evaluation of rationally chosen multitargeted drug combinations: a combination of low doses of levetiracetam, atorvastatin and ceftriaxone exerts antiepileptogenic effects in a mouse model of acquired epilepsy
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2018.05.035openalex-snapshot
Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2020.108213openalex-snapshot
The adenosine A1 receptor agonist WAG 994 suppresses acute kainic acid-induced status epilepticus in vivo
inferred← citeshttps://doi.org/10.1016/j.npep.2024.102415openalex-snapshot
A recent update on drugs and alternative approaches for parkinsonism
inferred← citeshttps://doi.org/10.1016/j.omton.2024.200911openalex-snapshot
Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer
inferred← citeshttps://doi.org/10.1016/j.pharmr.2024.100033openalex-snapshot
Shared molecular, cellular, and environmental hallmarks in cardiovascular disease and cancer: Any place for drug repurposing?
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2020.107579openalex-snapshot
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2020.107706openalex-snapshot
Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2021.107930openalex-snapshot
Drug repurposing for COVID-19: Approaches, challenges and promising candidates
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2021.107934openalex-snapshot
New approaches for developing multi-targeted drug combinations for disease modification of complex brain disorders. Does epilepsy prevention become a realistic goal?
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2025.108903openalex-snapshot
Antiviral drug repurposing: different approaches and the case of antifungal drugs
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2026.109051openalex-snapshot
Disarming the “Neural Hijack”: Repurposing neuroactive drugs for cancer therapy
inferred← citeshttps://doi.org/10.1016/j.phrs.2017.10.001openalex-snapshot
Linking energy sensing to suppression of JAK-STAT signalling: A potential route for repurposing AMPK activators?
showing the first 200 of 727 · page through all 727
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.